Pro Dex PDEX
NASDAQ PDEX
$59.84 -0.86 (-1.42%)
At close: Sep 10, 2026 · 4:00 PM EDT

Pro Dex (PDEX) Short term Debt (2011 - 2022)

Pro Dex's (PDEX) quarterly Short term Debt came in at $1.6 million in Q1 2022, up 30.32% quarter-over-quarter from $1.3 million in Q4 2021.

Analysis

Pro Dex (PDEX) Short term Debt (2011 - 2022) Analysis & Trends

Pro Dex has disclosed Short term Debt across 4 years of filings, most recently posting $1.6 million for Q1 2022.

  • In Q1 2022, Short term Debt changed N/A year-over-year to $1.6 million; the TTM figure through Mar 2022 stood at $1.6 million (changed N/A YoY), while the FY2021 annual figure was $1.2 million, changed N/A from the prior year.
  • Short term Debt came in at $1.6 million for Q1 2022 at Pro Dex, up from $1.3 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.6 million in Q1 2022 to a low of $1.2 million in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Pro Dex 192.84 Mn 183.45 Mn 7.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.64 Mn
Dec 31, 2021 1.26 Mn
Sep 30, 2021 1.25 Mn
Jun 30, 2021 1.24 Mn
Jun 30, 2012 774,000.00
Mar 31, 2012 357,000.00
Dec 31, 2011 357,000.00
Sep 30, 2011 357,000.00
Jun 30, 2011 357,000.00